Medicare Enrolled

Dr. Mark Mandel, MD

Ophthalmology · Hayward, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1237 B ST, Hayward, CA 94541
5108863937
In practice since 2006 (19 years)
NPI: 1770541294 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mandel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mandel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mandel

Dr. Mark Mandel is an ophthalmology specialist in Hayward, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mandel performed 1,831 Medicare services across 1,251 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mandel received a total of $4,121 from 24 pharmaceutical and/or device companies across 96 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mandel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 50% volume in CA $4,121 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,831
Medicare services
Top 50% in CA for ophthalmology
1,251
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~96 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
576 $22 $112
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
302 $80 $175
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
248 $127 $280
CT scan of cornea
A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye.
209 $35 $70
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
195 $109 $221
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
89 $35 $150
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
69 $288 $700
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
60 $39 $99
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
31 $31 $150
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
28 $112 $265
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
24 $51 $165
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.3% high complexity
18.0% medium
78.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,121
Total received (2018-2024)
Avg $589/year across 7 years
Top 28% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
96
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,121 (75.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,000 (24.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$889
2023
$453
2022
$1,675
2021
$172
2020
$311
2019
$447
2018
$173

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alcon Vision LLC
$307
BIOTISSUE HOLDINGS INC.
$251
RxSight Inc
$179
Glaukos Corporation
$56
ANI Pharmaceuticals, Inc.
$35
Astellas Pharma US Inc
$34
Apellis Pharmaceuticals, Inc.
$27
Top 3 companies account for 82.9% of 2024 payments
All-time payments by company (2018-2024) ›
Alcon Vision LLC
$1,280
GLAUKOS CORPORATION
$1,000
Johnson & Johnson Surgical Vision, Inc.
$394
BIOTISSUE HOLDINGS INC.
$251
RxSight Inc
$202
Novartis Pharmaceuticals Corporation
$134
Johnson & Johnson Vision Care, Inc.
$125
Allergan, Inc.
$112
Alcon Laboratories Inc
$100
Shire North American Group Inc
$66
Glaukos Corporation
$56
Carl Zeiss Meditec, Inc.
$49
Bausch & Lomb Americas Inc.
$48
Carl Zeiss Meditec USA, Inc.
$46
ABBVIE INC.
$43
ANI Pharmaceuticals, Inc.
$35
Astellas Pharma US Inc
$34
Apellis Pharmaceuticals, Inc.
$27
Sun Pharmaceutical Industries Inc.
$26
Horizon Therapeutics plc
$24
Aerie Pharmaceuticals, Inc.
$21
Thea Pharma Inc.
$18
Dompe US, Inc.
$16
Allergan Inc.
$15
Top 3 companies account for 64.9% of all-time payments
Associated products mentioned in payments ›
AcrySof IQ PanOptix · AcrySof IQ VIVITY · AcrySof IQ VIVITY IOL · Acuvue · CATALYS SYSTEM · CE-marked KXLA system · COMBIGAN · Centurion · Cequa · Clareon · CyPass · DAILIES · DURYSTA · HYDRUS Microstent · Izervay · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LUMIGAN · Luxor · MIEBO · ORA · OXERVATE · PURIFIED CORTROPHIN GEL · PanOptix · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · RXSIGHT INJECTOR HANDPIECE · ReSTOR · STAR S4 IR · Simbrinza · Syfovre · TECNIS IOL · TEPEZZA · TRAVATAN Z · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · Tecnis Symfony IOL · VUITY · VisuMax · XIIDRA · rhopressa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (76%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Hayward?
Compare ophthalmologists in the Hayward area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
523
Per 100K population
31.7
County median income
$126,240
Nearest hospital
WILLOW ROCK CENTER
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mandel is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mandel experienced with corneal topography and eye depth measurement?
Based on Medicare claims data, Dr. Mandel performed 576 corneal topography and eye depth measurement services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mandel receive payments from pharmaceutical companies?
Yes. Dr. Mandel received a total of $4,121 from 24 companies across 96 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mandel's costs compare to other ophthalmologists in Hayward?
Dr. Mandel's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mandel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →